Pharmaceutical Company

Yipinhong Pharmaceutical Aims to Boost R&D With US Unit

Yipinhong Pharmaceutical Aims to Boost R&D With US Unit

Chinese drugmaker Yipinhong Pharmaceutical Co. aims to boost research and development capacity overseas through the establishment of a USD5 million wholly-owned subsidiary in Delaware, US.

Apr 16, 2018
Tang Shihua
Chinese Firm Gains Approval for Anti-Malaria Drug Sales in Japan

Chinese Firm Gains Approval for Anti-Malaria Drug Sales in Japan

Chinese drugmaker Porton Fine Chemicals Ltd. has received the go-ahead from Japanese regulators to sell anti-malaria medicine in the country,…

Jan 19, 2018
Tang Shihua